Clinical Trial Update: Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of a fixed-dose combination of dutasteride and tamsulosin for six months in benign prostatic hyperplasia; study term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Dutasteride/tamsulosin fixed-dose combination

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 4 | Status: TERMINATED | Results posted: 2015-12-17